HMGB1 and ischemia reperfusion injury: In addition, HMGB1 is an important target in inflammatory processes; it has been shown in models of ischemia reperfusion injury (IRI), e.g., renal IRI, that the administration of an anti-HMGB1 antibody reduces inflammation.